Clinical Trial Update: Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers [NA]

View source ↗

Summary

Pilot trial evaluating whether supplementation with Vitamin K2 MK-7 and Vitamin D3 impacts Post-acute COVID-19 syndrome symptoms and inflammatory biomarkers. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome

Drugs mentioned

• Vitamin D3 (Cholecalciferol)
• Vitamin K2 MK-7 (menaquinone-7)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Post-acute COVID-19 Syndrome | NA | Status: COMPLETED